Dr Scott Michael Reis, MD | |
5251 W Highway 290, Austin, TX 78735-8963 | |
(512) 654-3000 | |
(713) 791-0703 |
Full Name | Dr Scott Michael Reis |
---|---|
Gender | Male |
Speciality | Plastic And Reconstructive Surgery |
Experience | 14 Years |
Location | 5251 W Highway 290, Austin, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1699092965 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | Q5544 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Baylor Scott & White Medical Center - Round Rock | Round rock, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Scott And White Clinic | 8123923604 | 2131 |
News Archive
Research presented at this year's Euroanaesthesia exploring the protective effect of various heart medications that patients are taking before undergoing coronary artery bypass graft (CABG) surgery concludes that statins reduce the risk of death by two thirds, or 67 percent, while no consistent effects were seen for other medications.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that the U.S. Food and Drug Administration has provided guidance on the clinical program required to assess the approvability of Restanza™ (cethromycin), a novel oral once-a-day antibiotic, in the treatment of outpatient community acquired bacterial pneumonia (CABP) as well as biodefense indications including anthrax, plague and tularemia.
The overall health of Australians continues to improve, however, a new report from the Australian Institute of Health and Welfare for 2018 show that further gains could be achieved by reducing leading risk factors such as tobacco use, overweight, and high blood pressure.
You've heard of on-demand TV, now imagine on-demand medical diagnosis - anytime, anywhere in the world. Scientists at GE Global Research, the technology development arm of the General Electric Co. (NYSE: GE), are working with a team based at the University of Washington to develop a new medical device, the size of a pack of playing cards, that can detect infectious disease by way of a simple nasal swab, in less than an hour.
PolyMedix, Inc., an emerging biotechnology company developing new therapeutic drug products to treat infectious diseases and acute cardiovascular disorders based on biomimetics, has received patent protection for certain exclusively licensed intellectual property by the issuance to the University of Pennsylvania of U.S. patent number 7,590,517, "Methods, Systems, and Computer Program Products for Computational Design of Amphiphilic Polymers."
› Verified 8 days ago
Entity Name | Scott & White Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093779704 PECOS PAC ID: 8123923604 Enrollment ID: O20031223000640 |
News Archive
Research presented at this year's Euroanaesthesia exploring the protective effect of various heart medications that patients are taking before undergoing coronary artery bypass graft (CABG) surgery concludes that statins reduce the risk of death by two thirds, or 67 percent, while no consistent effects were seen for other medications.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that the U.S. Food and Drug Administration has provided guidance on the clinical program required to assess the approvability of Restanza™ (cethromycin), a novel oral once-a-day antibiotic, in the treatment of outpatient community acquired bacterial pneumonia (CABP) as well as biodefense indications including anthrax, plague and tularemia.
The overall health of Australians continues to improve, however, a new report from the Australian Institute of Health and Welfare for 2018 show that further gains could be achieved by reducing leading risk factors such as tobacco use, overweight, and high blood pressure.
You've heard of on-demand TV, now imagine on-demand medical diagnosis - anytime, anywhere in the world. Scientists at GE Global Research, the technology development arm of the General Electric Co. (NYSE: GE), are working with a team based at the University of Washington to develop a new medical device, the size of a pack of playing cards, that can detect infectious disease by way of a simple nasal swab, in less than an hour.
PolyMedix, Inc., an emerging biotechnology company developing new therapeutic drug products to treat infectious diseases and acute cardiovascular disorders based on biomimetics, has received patent protection for certain exclusively licensed intellectual property by the issuance to the University of Pennsylvania of U.S. patent number 7,590,517, "Methods, Systems, and Computer Program Products for Computational Design of Amphiphilic Polymers."
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Scott Michael Reis, MD Po Box 844658, Dallas, TX 75284-4658 Ph: () - | Dr Scott Michael Reis, MD 5251 W Highway 290, Austin, TX 78735-8963 Ph: (512) 654-3000 |
News Archive
Research presented at this year's Euroanaesthesia exploring the protective effect of various heart medications that patients are taking before undergoing coronary artery bypass graft (CABG) surgery concludes that statins reduce the risk of death by two thirds, or 67 percent, while no consistent effects were seen for other medications.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that the U.S. Food and Drug Administration has provided guidance on the clinical program required to assess the approvability of Restanza™ (cethromycin), a novel oral once-a-day antibiotic, in the treatment of outpatient community acquired bacterial pneumonia (CABP) as well as biodefense indications including anthrax, plague and tularemia.
The overall health of Australians continues to improve, however, a new report from the Australian Institute of Health and Welfare for 2018 show that further gains could be achieved by reducing leading risk factors such as tobacco use, overweight, and high blood pressure.
You've heard of on-demand TV, now imagine on-demand medical diagnosis - anytime, anywhere in the world. Scientists at GE Global Research, the technology development arm of the General Electric Co. (NYSE: GE), are working with a team based at the University of Washington to develop a new medical device, the size of a pack of playing cards, that can detect infectious disease by way of a simple nasal swab, in less than an hour.
PolyMedix, Inc., an emerging biotechnology company developing new therapeutic drug products to treat infectious diseases and acute cardiovascular disorders based on biomimetics, has received patent protection for certain exclusively licensed intellectual property by the issuance to the University of Pennsylvania of U.S. patent number 7,590,517, "Methods, Systems, and Computer Program Products for Computational Design of Amphiphilic Polymers."
› Verified 8 days ago
Sally Matika, PA-C Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 6818 Austin Center Blvd Ste 204, Austin, TX 78731 Phone: 512-867-6211 | |
Mr. James Thomas Robison Iv, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5656 Bee Cave Rd, Suite J-200, Austin, TX 78746 Phone: 512-450-1077 Fax: 512-450-1817 | |
Kelly Eugene Tjelmeland, M D Plastic Surgery Medicare: Medicare Enrolled Practice Location: 4220 Bull Creek Rd, Austin, TX 78731 Phone: 512-617-7500 | |
E Richard Parker, M. D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 4220 Bull Creek Rd, Austin, TX 78731 Phone: 512-617-7500 | |
Dr. Sanjay Kumar Sharma, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1400 N Ih 35, Suite 320, Austin, TX 78701 Phone: 512-324-8320 Fax: 512-324-8323 | |
Dr. Dustin Leon Reid, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 901 W 38th St, Suite 401, Austin, TX 78705 Phone: 512-371-8817 Fax: 512-371-8819 | |
Dr. David Brian Dellinger, DO Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 11623 Angus Rd, Suite C15, Austin, TX 78759 Phone: 512-229-1978 Fax: 512-229-1978 |